Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge

被引:16
作者
Georgitis, JW
Meltzer, EO
Kaliner, M
Weiler, J
Berkowitz, R
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27157 USA
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Inst Asthma Allergy, Washington, DC USA
[4] Univ Iowa, Dept Med, Iowa City, IA 52242 USA
[5] Atlanta Allergy & Asthma, Atlanta, GA USA
关键词
D O I
10.1016/S1081-1206(10)62280-6
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Medications containing a combination antihistamine-decongestant are commonly used for allergic rhinitis yet onset-of-action comparisons for symptom relief after a single dose have not been performed. Objective: To determine the onset of symptom relief and efficacy of antihistamine-decongestant medications (acrivastine-pseudoephedrine and loratadine-pseudoephedrine) compared with placebo in an outdoor park. Methods: This study was conducted during the spring of 1997 using a double-blind, placebo-controlled design. Patients completed baseline rhinitis symptom diaries from 7:30 to 9:30 AM. Subjects with qualifying symptom scores received one dose of either acrivastine-pseudoephedrine, loratadine-pseudoephedrine, or placebo at 10:00 AM. Symptom diaries were recorded for the next 4 hours. Results: Of 593 patients randomized to treatment, 592 were included in efficacy analysis. Acrivastine-pseudoephedrine and loratadine-pseudoephedrine demonstrated a mean onset-of-action by 45 and 30 minutes respectively for total symptom and rhinitis symptom scores for the five sites. Onset-of-action for nasal congestion scores was 45 minutes for both medications. Sites having higher pollen exposure (>100 pollen grains over 6 hours) demonstrated a difference between the antihistamine combinations: acrivastine-pseudoephedrine had an onset of action at 45 minutes for total symptom and rhinitis symptom scores, and 15 minutes for nasal congestion scores whereas loratadine-pseudoephedrine had onset-of-action for nasal congestion score of 105 minutes but failed to reach significance at any timepoint for total symptom and rhinitis symptom scores. Conclusions: Both antihistamine-decongestant combinations demonstrate an onset-of-action within 60 minutes of administration but under conditions of higher pollen exposure, the acrivastine combination was more effective for total symptoms, rhinitis symptoms, and nasal congestion with an onset-of-action within 45 minutes for rhinitis symptoms and 15 minutes for congestion.
引用
收藏
页码:451 / 459
页数:9
相关论文
共 42 条
[1]   Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis [J].
Abdelaziz, MM ;
Devalia, JL ;
Khair, OA ;
Bayram, H ;
Prior, AJ ;
Davies, RJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (03) :410-420
[2]   ANTIALLERGIC EFFECTS OF TERFENADINE ON IMMEDIATE TYPE HYPERSENSITIVITY REACTIONS [J].
AKAGI, M ;
MIO, M ;
MIYOSHI, K ;
TASAKA, K .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1987, 9 (2-3) :257-279
[3]  
[Anonymous], DESIGN ANAL CLIN EXP
[4]   ACRIVASTINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN ALLERGIC RHINITIS, URTICARIA AND RELATED DISORDERS [J].
BROGDEN, RN ;
MCTAVISH, D .
DRUGS, 1991, 41 (06) :927-940
[5]  
BUSH RK, 1997, HDB ASTHMA RHINITIS
[6]  
CHERVINSKY P, 1994, ANN ALLERGY, V73, P109
[7]   A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis [J].
Day, JH ;
Buckeridge, DL ;
Clark, RH ;
Briscoe, MP ;
Phillips, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (05) :1050-1057
[8]   Cetirizine, Ioratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit [J].
Day, JH ;
Briscoe, M ;
Widlitz, MD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (05) :638-645
[9]   Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit [J].
Day, JH ;
Briscoe, MP ;
Welsh, A ;
Smith, JN ;
Clark, A ;
Ellis, AK ;
Mason, J .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 79 (06) :533-540
[10]  
DAY JH, 1997, ANN ALLERG ASTHMA IM, V79, P63